共沉淀预富集氟化辅助ETV－ICP－AES测定高纯氧化钇中痕量钒

提出吡咯烷二硫代氨基甲酸铵为沉淀剂，Ｂｉ（ＰＤＣ）３共沉淀分离预富集氟化辅助ＥＴＶ－ＩＣＰ－ＡＥＳ测定高纯Ｙ２Ｏ３中痕量钒的新方法。分离基体后的杂质浓缩物不需用酸溶解，而是制成悬浮体直接引入石墨炉蒸发，采用水溶液标准工作曲线测定沉淀物中的钒。本法测定钒的检出限为１．１ｎｇ／ｍｌ，ＲＳＤ为２．８％（ｎ＝１０，ｃ＝１５ｎｇ／ｍｌ），实际试样分析的回收率＞９６％。     

2-氰基-2,3,3-三甲基-5-硫代-吡咯烷的合成新法

以3,3-二甲基-4-戊烯酸甲酯为原料, 经过6步反应合成了目标产物2-氰基-2,3,3-三甲基-5-硫酮-吡咯烷, 反应的总收率约为37%, 其中关键步骤为分子内环化和碘化氢消除反应. 通过元素分析, ¹H NMR, IR和MS对所合成化合物的结构进行了表征.     

高效催化不对称还原潜手性二酮及产物在合成1，5－二苯基吡咯烷和1，5－二苯基噻吩烷中的应用

本文报道了一种高效不对称催化还原潜手性二酮的方法，该方法使用的是简便易得的NaBH₄和路易斯酸SnCl₂现场产生硼烷，以天然的L-脯氨酸经过简单的转化所得的 (S)-(-)-α, α-二苯基-吡咯烷甲醇作为手性催化剂，该方法对大部分二酮的还原都非常有效，尤其是对1，4 二酮及1，5 二酮的还原，可以得到极好的非对映选择性和对映选择性（up to>99% e e）。还原所得的手性二醇本身是非常有效的手性催化剂同时可以转化成其它有意义的手性催化剂和辅基，而且许多天然产物中都含有手性二醇的结构单元。本文还报道了由光学活性的1，4二醇合成的1，5－二苯基吡咯烷和1，5－二苯基噻吩烷的方法，这两类化合物都是不对称合成中应用广泛的手性催化剂。     

α-乙酰氧基-N-亚硝基吡咯烷的解离及其致癌代谢机理的理论研究

用ab initio方法, 在MP2/6-31G**水平下讨论了α-乙酰氧基-亚硝基吡咯烷(α-Acetoxy-NPYR)在各种条件下的解离反应机理, 并对形成终致癌物B, C, D的代谢机理进行研究. 发现在OH^－和H₂O作用下的解离都遵循羟基进攻羰基机理, OH^－作用下是一个经四面体中间体阴离子的无位垒过程, H₂O作用下有相对高的活化能(165.36 kJ/mol). H₃O^＋作用下是先形成阳离子产物的S_N1过程, 并没有发现遵循两种综合的解离情形. 同时, 羟基化产物异构化为终致癌物B, C, D是一个相对容易进行的过程.     

二聚体有机锡配合物{[n-Bu2Sn(O2CCH2CS2NC4H8)]2O}2的合成，表征及晶体结构(英)

The title compound, {[n-Bu₂Sn(O₂CCH₂CS₂NC₄H₈)]₂O}₂, has been synthesized by the reaction of (tetrahydro-pyrrodithiolocarbamoylthio)acetic acid with the di-n-bubyltin oxide in 1∶1 molar ratio. The complex has been characterized by elemental analysis, IR and NMR. The crystal structure of it has been determined by X-ray single crystal diffraction. And the results showed that the crystal belongs to triclinic system with space group P1 and some crystal parameters: a=1.220 2(9) nm, b=1.315 8(10) nm, c=1.380 4(10) nm, α=111.215(9)°， β=99.357(9)°， γ=96.075(10)°, V=2.006(2) nm³, Z=1, F(000)=908, μ=1.489 mm^-1, D_c=1.474 g·cm^-3, R₁=0.037 5, wR₂=0.0839. The complex has a centrosymmetric dimer structure mode with a four-membered central endo-cyclic Sn₂O₂ unit in which two bridged oxygen atoms both connect with an exo-cyclic tin atom which has a distorted octahedron. Each of the endo-cyclic tin atoms exhibits a distorted trigonal bipyramid coordination geometry with an additional weak coordination carboxylate oxygen. Four carboxylate ligands are divided into two types. And two of them are bidentate and connecting to each of exo-cyclic tin atoms by using both oxygen atoms, whereas the others bridge to each pair of exo-and endo-cyclic tin atoms utilizing one oxygen atom only. CCDC: 220513.     

三元配合物Tm[(C5/sub>H8NS2)3(C12H8N2)]的热化学性质研究

在无水乙醇中，用吡咯烷二硫代氨基甲酸铵(APDTC)和1,10-邻菲咯啉(o-phen·H₂O)与TmCl₃·3.65H₂O作用，合成了未见文献报道的三元固态配合物，确定它的组成为Tm[(C_{5/sub>H8NS2)3(C12H8N2)]。 用RD496-Ⅲ微量热计测定了298.15 K下水合氯化铥及两个配体在无水乙醇中的溶解焓，两个配体醇溶液的混合焓及不同温度下标题化合物液相生成反应的焓变。在实验和计算基础上，得到了液相生成反应的热力学参数(活化焓、活化熵和活化自由能)，速率常数和动力学参数(表现活化能、频率因子和反应级数)。通过合理的热化学循环，求得了298.15 K时标题化合物的固相生成反应焓变；推导了用该热量计测定固态物质比热容的计算式，并测定了题目配合物298.15 K的比热容。用RBC-Ⅱ精密转动弹热量计测定了题目配合物的恒容燃烧热， 计算了它们的标准摩尔燃烧焓和标准摩尔生成焓。}     

雨水中微量银的萃取无焰原子吸收光谱测定

碘化银人工增雨水样以及天然雨雪中微量银的无焰原子吸收测定通常要采用离子交换,二乙基二硫代氯氨基甲酸二乙铵溶于甲基异丁酮萃取,双硫腙——四氯化碳萃取,阴离子树脂分离后再用吡咯烷二硫代甲酸铵水溶液萃取,硫代磷酸三辛酯——甲基异丁酮萃取,再以盐酸反萃,吡咯烷二硫代甲酸铵水溶液——甲基异丁     

C60-吡咯烷衍生物的合成及非线性光学性质的研究

通过富勒烯C₆₀与肌氨酸和有机醛化合物的1,3-偶极环加成反应, 获得了九种含不同有机功能基团的C₆₀吡咯烷衍生物1～9, 用¹H NMR, ¹³C NMR, FTIR, UV-vis和FAB-MS进行了结构表征; 利用皮秒激光光源, 采用z扫描技术测定了分子的三阶非线性超极化率γ⁽³⁾, 结果显示: 化合物3 (γ⁽³⁾＝4.14×10^－33 esu)具有最大的三阶非线性光学系数, 说明增加噻吩共轭链的长度, 使三阶非线性活性增加; 对具有相同共轭链的C₆₀-噻吩吡咯烷衍生物(2, 5, 1和4), 吸电子取代基减小了三阶光学非线性活性, 给电子基增大了三阶光学非线性活性; 同时发现喹啉环2-位键联(7)比4-位(8)有更好的三阶光学非线性活性.     

A High－efficiency Preparation, Properties and Structure of （R, S ）－and （ S, S）－Pyrrolidine－2－carboxylic Acid 3,5－Dioxa－4－boracvclo.hepta [ 2,1－α; 3,4－α′] dinaphthalen－4－yl Esters

A highly-efficient preparative procedure for ( R, S )- and ( S, S)-pyrroHdine-2-carboxyHc acid 3,5-dioxa-4-boracyclohepta[2, 1-α ; 3,4-α′] dlnaphthalen-4-yl esters [ namely ( R, S )-BNBAP and (S, S )-BNBAP] is described and the crystal structure of (R, S )-BNBAP was obtained. The data indicate that ( R, S )-BNBAP is a spirocyclic inner borate salt with almost normal te-trahedral configuration. This structural form may be the basic reason for their high chemical, optical and thermodynamic sta-bility.     

Design and Synthesis of Tri-substituted Chiral Pyrrolidin-2-one Derivatives as CCR4 Antagonists

A series of tri-substituted chiral pyrrolidin-2-one derivatives have been designed and synthesized as CC chemokine receptor 4 （CCR4） antagonists. The structure of CCR4 was built by homology modeling. Asymmetric synthesis was applied to synthesize the R,R configuration chiral pyrrolidin-2-one scaffold. The stereoisomeric con- figurations of the compounds were identified by 2D I H-~H COSY spectroscopy and 1D NOESY spectroscopy. This method was more economical and convenient than traditional X-ray single crystal diffraction. In addition, the inter- actions between these compounds and the N-terminal extracellular tail of CCR4 were studied using capillary zone electrophoresis. The CCR4 chemotaxis inhibition effect was tested in CCR4-transfected HEK293 cells. Several compounds showed potent activities as CCR4 antagonists. Among these compounds, lc is the most active one. Its apparent binding constant of CZE experiment result is （1.569±0.11）× 10s L·mol ^-1, and its percentage inhibition of the HEK293/CCR4 cells migration with the concentration of I gmol·L ^-1 in DMSO is 59%. And compound If has slightly higher affinity to N-terminal of CCR4 according to its apparent binding constant than lb because of the in- troduced ester linkage. Further studies on the mechanism of these compounds are in progress.